UMass Boston Blog Network Part of the UMass Boston Blog Network

Venture Development Center

« Revolutionary ideas start here (IDEAS Boston) | Home | Start-up interns (To help you launch!) »

New Jersey biotech startup moves to VDC

This week OFT Labs moved its research and development operation from New Jersey to UMass Boston’s Venture Development Center, to collaborate with another company in the incubator, GeoMed Analytical.

The two firms earlier announced the results of a clinical trial for an oral fluid lead test designed and correlated by Dr. Anil T. Mangla, Chief Lead Epidemiologist for the Division of Public Health in Atlanta. This trial was completed at Emory University Hospital.

“The success of this study is a milestone for lead testing on a universal scale,” said Dr. Mangla.

Until now, the only accurate way to test for lead poisoning was through invasive needle or finger sticks. The trial found that oral fluid swabs can be used successfully to measure lead levels in children.

The analytical technique was invented by UMass Boston’s Dr. Robyn Hannigan, a researcher in heavy metals and neurological diseases, and founder of GeoMed Analytical. - WJB

Get a Trackback link

No Comments Yet

You can be the first to comment!

Leave a comment